Peptides can target skin ageing.
Peptides limit the onset of wrinkles at various levels. Some, such as palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl pentapeptide-4 (Pal-KTTKS), directly stimulate fibroblast activity, promoting the production of collagen, elastin and glycosaminoglycans to reinforce skin structure and suppleness. Others, such as palmitoyl tripeptide-3/5, mimic extracellular matrix proteins, thereby both enhancing collagen synthesis and curbing its degradation. Finally, neurotransmitter-inhibitor peptides, such as argireline, act on acetylcholine release to reduce the muscle contractions responsible for expression lines, thus providing a smoothing effect.
Peptides mitigate oxidative stress.
The oxidative stress resulting from an imbalance between the production of free radicals and the skin’s ability to neutralise them. Unstable, these free radicals can react with skin components, such as structural proteins in the dermis, for instance, and alter them, thus accelerating skin laxity. Certain peptides possess antioxidant properties that may be valuable in preventing this phenomenon. Indeed, carnosine, for example, can neutralise free radicals and limit lipid peroxidation within cell membranes. Their efficacy depends on their molecular structure: peptides rich in hydrophobic amino acids such as leucine, alanine or proline, or aromatic residues such as tryptophan or histidine, have a greater capacity to donate electrons to free radicals.
Peptides can accelerate skin wound healing.
Certain peptides, such as LL-37, can be involved in skin repair. They exert an immunomodulatory action that balances inflammatory responses and creates an environment favourable to tissue regeneration. Research conducted on human fibroblasts has shown that these peptides activate the transcription of genes involved in proliferation, such as KI67, and in cell migration, such as CXCR4, two important steps in the process of wound healing. Other peptides, such as hBD-2 and hBD-3, support skin repair by activating the FGFR1/JAK2/STAT3 signalling pathway, known to favour angiogenesis.
Peptides can support skin hydration.
Certain biomimetic peptides actively contribute to skin hydration by promoting water retention in the epidermis. A 30-day clinical trial conducted on 20 women evaluated a hydrogel enriched with SH-oligopeptide-2, SH-polypeptide-1, SH-oligopeptide-1 and SH-polypeptide-42. The results revealed an average increase in hydration of 13.8% after 30 minutes, rising to 17.5% after one hour, compared with 9.7% for the placebo. These biomimetic peptides also enhanced skin elasticity, emphasising their comprehensive action.
Peptides have a soothing potential.
Certain peptides are particularly beneficial for sensitive or reactive skin, thanks to their ability to modulate inflammation and strengthen the skin barrier. Acetyl dipeptide-1 cetyl ester is a prime example: it acts on the POMC gene pathway, stimulating the production of endogenous peptides such as α-MSH, which is known to regulate inflammatory responses. It also enhances the expression of genes essential to skin cohesion, including aquaporin-3 and filaggrin, while reducing the synthesis of prostaglandin E2, a mediator involved in redness and irritation. These combined actions contribute to the skin’s day-to-day comfort.
Peptides exhibit antimicrobial activity.
Certain peptides exhibit antibacterial properties, which can be particularly useful for preventing blemishes. Peptides such as P156, derived from the phage lysin Prevotella intermedia (PlyPi01), have shown targeted activity against Cutibacterium acnes and Staphylococcus aureus, two bacteria involved in acne-related skin inflammation. If these effects were confirmed in vivo, owing to their antibacterial and anti-inflammatory properties, these peptides could be promising additions for blemish-prone skin.